Coagulation & Platelets Testing
Coagulation, Platelets, Rare Disease & Genetics
Coagulation & Platelets Testing
Our Coagulation Experts Provide Valuable Guidance to Expedite Results
We help you assess enzymatic function, cellular function, antigen expression, inhibitor profiles and gene sequences of clinically important coagulation and platelet markers.
High quality testing starts the moment blood is drawn. Clinical samples for coagulation and platelet testing are some of the most fragile specimens tested in laboratory medicine.
Careful selection of reagents, methodologies and biochemistries require broad knowledge of advanced hemostasis. Our clinical and technical consultation help you interpret your test results to achieve the best patient care.
Why test with us:
- We pride ourselves on being the fastest lab in the US
- Our reagent selection insures some of the highest clinical sensitivity and specificity in the industry
- We offer a comprehensive menu of specialized coagulation and platelet testing
By Specialty
- von Willebrand Disease
- Platelet Functional Defects
- Hemophilia A, B and others
- Heparin-induced Thrombocytopenia (HIT)
- Thrombophilia
- Thrombotic Microangiopathy (TMA)
- Advanced Genetics
- Antiphospholipid Syndrome
- Complement-mediated TMAs
- COVID-associated thrombosis
- Factor Deficiencies and Inhibitors
- Lupus Anticoagulants
Brad Lewis, MD
Chief Medical Director
Dr. Lewis is an internationally recognized expert in the diagnosis and management of bleeding, clotting and complement-mediated disorders. He has been with Machaon since its founding in 2003 and provides clinical consultation to our physicians, pharmaceutical and hospital clients. He is a regular laboratory inspector of the College of American Pathologists (CAP).
| BS | MIT |
|---|---|
| MA | Brandeis University |
| MD | UCLA School of Medicine |
| Fellowship | University of Rochester |
Brad Lewis, MD
PAI-1 with Dr. Brad Lewis
Blood, Sweat and Smears is a podcast hosted by Dr. Brad Lewis. This podcast focuses on bleeding, clotting and complement-mediated disorders, as well as related news and events shaping current approaches in clinical management and laboratory medicine. Dr. Lewis shares his insights and knowledge, built over his four decades as a benign hematologist.
Need our expertise?
Only 3% of pharmaceutical drugs make it to market.
